INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis
NASDAQ:ISRG - Nasdaq - US46120E6023 - Common Stock - Currency: USD
ISRG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ISRG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make ISRG suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year ISRG was profitable.
In the past year ISRG had a positive cash flow from operations.
Each year in the past 5 years ISRG has been profitable.
In the past 5 years ISRG always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 12.39%, ISRG belongs to the best of the industry, outperforming 93.62% of the companies in the same industry.
The Return On Equity of ISRG (14.05%) is better than 88.30% of its industry peers.
ISRG has a better Return On Invested Capital (12.81%) than 93.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 8.19%.
The 3 year average ROIC (12.30%) for ISRG is below the current ROIC(12.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.39% | ||
| ROE | 14.05% | ||
| ROIC | 12.81% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)12.3%
ROIC(5y)11.92%
1.3 Margins
ISRG has a Profit Margin of 27.81%. This is amongst the best in the industry. ISRG outperforms 96.81% of its industry peers.
ISRG's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 28.14%, ISRG belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
ISRG's Operating Margin has declined in the last couple of years.
The Gross Margin of ISRG (67.46%) is better than 73.40% of its industry peers.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.14% | ||
| PM (TTM) | 27.81% | ||
| GM | 67.46% |
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRG is creating some value.
ISRG has more shares outstanding than it did 1 year ago.
ISRG has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.4
WACC9.14%
2.3 Liquidity
A Current Ratio of 5.22 indicates that ISRG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.22, ISRG is in the better half of the industry, outperforming 77.13% of the companies in the same industry.
ISRG has a Quick Ratio of 4.54. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
ISRG has a better Quick ratio (4.54) than 79.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.22 | ||
| Quick Ratio | 4.54 |
3. Growth
3.1 Past
ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.37%, which is quite impressive.
ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
ISRG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.24%.
Measured over the past years, ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)28.37%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%38.12%
Revenue 1Y (TTM)17.24%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%25.16%
3.2 Future
Based on estimates for the next years, ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.44% on average per year.
Based on estimates for the next years, ISRG will show a quite strong growth in Revenue. The Revenue will grow by 14.11% on average per year.
EPS Next Y12.03%
EPS Next 2Y14.8%
EPS Next 3Y15.12%
EPS Next 5Y14.44%
Revenue Next Year17.22%
Revenue Next 2Y16.42%
Revenue Next 3Y15.97%
Revenue Next 5Y14.11%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 80.74, which means the current valuation is very expensive for ISRG.
65.96% of the companies in the same industry are more expensive than ISRG, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ISRG to the average of the S&P500 Index (29.63), we can say ISRG is valued expensively.
Based on the Price/Forward Earnings ratio of 72.06, the valuation of ISRG can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 68.09% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.74 | ||
| Fwd PE | 72.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ISRG is valued a bit cheaper than the industry average as 65.43% of the companies are valued more expensively.
ISRG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 67.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 161.89 | ||
| EV/EBITDA | 72.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ISRG may justify a higher PE ratio.
A more expensive valuation may be justified as ISRG's earnings are expected to grow with 15.12% in the coming years.
PEG (NY)6.71
PEG (5Y)7.03
EPS Next 2Y14.8%
EPS Next 3Y15.12%
5. Dividend
5.1 Amount
No dividends for ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
591.79
-14.78 (-2.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.44%
Inst Owner Change0.74%
Ins Owners0.5%
Ins Owner Change-3.1%
Market Cap211.07B
Analysts80.51
Price Target652.64 (10.28%)
Short Float %1.19%
Short Ratio2.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.57%
Min EPS beat(2)10.37%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)12.24%
Min EPS beat(4)4.44%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)7.68%
EPS beat(12)10
Avg EPS beat(12)4.92%
EPS beat(16)13
Avg EPS beat(16)7.19%
Revenue beat(2)1
Avg Revenue beat(2)2.49%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)5.12%
Revenue beat(4)1
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.53%
Revenue beat(12)5
Avg Revenue beat(12)0%
Revenue beat(16)7
Avg Revenue beat(16)1.66%
PT rev (1m)9.5%
PT rev (3m)17.5%
EPS NQ rev (1m)-2.11%
EPS NQ rev (3m)0.74%
EPS NY rev (1m)2.31%
EPS NY rev (3m)2.4%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)0.74%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.74 | ||
| Fwd PE | 72.06 | ||
| P/S | 25.27 | ||
| P/FCF | 161.89 | ||
| P/OCF | 87.4 | ||
| P/B | 12.77 | ||
| P/tB | 13.04 | ||
| EV/EBITDA | 72.8 |
EPS(TTM)7.33
EY1.24%
EPS(NY)8.21
Fwd EY1.39%
FCF(TTM)3.66
FCFY0.62%
OCF(TTM)6.77
OCFY1.14%
SpS23.42
BVpS46.35
TBVpS45.37
PEG (NY)6.71
PEG (5Y)7.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.39% | ||
| ROE | 14.05% | ||
| ROCE | 14.22% | ||
| ROIC | 12.81% | ||
| ROICexc | 27.51% | ||
| ROICexgc | 28.82% | ||
| OM | 28.14% | ||
| PM (TTM) | 27.81% | ||
| GM | 67.46% | ||
| FCFM | 15.61% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)12.3%
ROIC(5y)11.92%
ROICexc(3y)22.09%
ROICexc(5y)21.23%
ROICexgc(3y)23.21%
ROICexgc(5y)22.47%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score7
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 222.37% | ||
| Cap/Sales | 13.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 84.73% | ||
| Profit Quality | 56.14% | ||
| Current Ratio | 5.22 | ||
| Quick Ratio | 4.54 | ||
| Altman-Z | N/A |
F-Score7
WACC9.14%
ROIC/WACC1.4
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.37%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%38.12%
EPS Next Y12.03%
EPS Next 2Y14.8%
EPS Next 3Y15.12%
EPS Next 5Y14.44%
Revenue 1Y (TTM)17.24%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%25.16%
Revenue Next Year17.22%
Revenue Next 2Y16.42%
Revenue Next 3Y15.97%
Revenue Next 5Y14.11%
EBIT growth 1Y32.03%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year37.81%
EBIT Next 3Y24.38%
EBIT Next 5Y19.91%
FCF growth 1Y73.93%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y33.15%
OCF growth 3Y4.95%
OCF growth 5Y8.61%